Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Carolyn Owen, Sarah Eisinga, Versha Banerji, Nathalie Johnson, Alina S. Gerrie, Andrew Aw, Christine Chen, Sue Robinson
Author Archives: ScienceDirect Publication: Leukemia Research
PI3K/AKT inhibitor BEZ-235 targets CCND2 and induces G1 arrest in breast implant-associated anaplastic large cell lymphoma
Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Stefan Nagel, Anja Fischer, Susanne Bens, Vivien Hauer, Claudia Pommerenke, Cord C. Uphoff, Margarete Zaborski, Reiner Siebert, Hilmar Quentmeier
Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives
Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Muhlis Cem Ar, Riad El Fakih, Saule Gabbassova, Ahmad Alhuraiji, Fady Nasr, Ahmad Alsaeed, Nilgun Sayinalp, Mahmoud Marashi
A rare BCR-ABL1 transcript in chronic myeloid leukemia: Case report and literature review
Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Zhen-Yu Zhao, Nan Tang, Li-Er Lin
Corrigendum to “Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities” [Leuk. Res. 130 (2023) 1–7]
Publication date: October 2023
Source: Leukemia Research, Volume 133
Author(s): Ismail Elbaz Younes, Lee Syler, Amira Hamed
The shifting therapeutic paradigm for relapsed/refractory mantle cell lymphoma
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Sumukh Arun Kumar, Jenny Gao, Shyam A. Patel
AML with <em>CEBPA</em> mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Davidson Zhao, Qianghua Zhou, Mojgan Zarif, Entsar Eladl, Cuihong Wei, Eshetu G. Atenafu, Andre Schuh, Anne Tierens, Yu Wing Tony Yeung, Mark D. Minden, Hong Chang
MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Gunnar Larfors, Daniel Moreno Berggren, Hege Garelius, Lars Nilsson, Bengt Rasmussen, Eva Hellström-Lindberg, Elisabeth Ejerblad
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Swe Mar Linn, Igor Novitzky-Basso, Christopher Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations
Publication date: November 2023
Source: Leukemia Research, Volume 134
Author(s): Shyam A. Patel, Elisa Bello, Andrew Wilks, Jonathan M. Gerber, Narayanan Sadagopan, Jan Cerny